Kurashiki, Japan

Takahiro Sekiguchi

USPTO Granted Patents = 11 


 

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 21(Granted Patents)


Location History:

  • Okayama, JP (2014)
  • Kurashiki, JP (2011 - 2015)
  • Ashigarakami-gun, JP (2021)

Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: The Innovative Mind of Takahiro Sekiguchi

Introduction

Takahiro Sekiguchi is a notable inventor hailing from Ashigarakami-gun, Japan. With a total of three patents to his name, Sekiguchi's contributions to the field of pharmaceuticals, particularly in liposome compositions and tumor therapeutics, are groundbreaking. His work focuses on providing effective treatments for cancer through innovative methods involving lipid technology.

Latest Patents

One of Sekiguchi's latest patents is a liposome composition and method for producing the same. The primary objective of this invention is to deliver a liposome that has an excellent leakage rate of a nucleic acid analog anticancer agent. This composition is designed to enhance the efficacy of treatment by ensuring that the anticancer agent remains stable and effective within the body. The specifications of the invention include a specific content ratio of lysophospholipid and a precise nucleic acid analog anticancer agent/lipid ratio, which facilitates optimal therapeutic effects.

Another significant patent is the development of a tumor therapeutic agent and a kit containing a gemcitabine liposome composition. This invention aims to surpass the antitumor effects of existing treatments like gemcitabine and taxane antitumor agents. By combining a taxane antitumor agent with a specialized liposome composition containing gemcitabine, Sekiguchi's innovative approach offers new hope in cancer therapy.

Career Highlights

Takahiro Sekiguchi is associated with Fujifilm Corporation, where he utilizes his expertise to develop cutting-edge medical technologies. His work at Fujifilm reflects the company’s commitment to innovation in the healthcare sector and highlights the significant role that research and development play in the advancement of medical treatments.

Collaborations

Throughout his career, Sekiguchi has collaborated with talented individuals such as Mikinaga Mori and Tsukasa Kitahashi. These collaborations have fostered a rich exchange of ideas and have led to the successful development of impactful inventions within the pharmaceutical field.

Conclusion

As a pioneering inventor, Takahiro Sekiguchi's contributions to liposome technology and cancer treatment represent significant advancements in medical science. His patents not only showcase his creativity and scientific acumen but also hold the potential to improve therapeutic outcomes for cancer patients worldwide. The innovative spirit of Sekiguchi exemplifies the vital intersection of research and practical application in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…